AXT Inc. filed an 8-K revealing that due to the passing of a director, they no longer meet Nasdaq's requirement for an independent audit committee, with a notification date of July 14, 2025, and a cure period until July 11, 2026 or January 7, 2026. The company plans to add a new independent director to regain compliance.